Important change to heparin container labels to clearly state the total drug strength.

Provide Feedback |

Submit a Case

Government Resource

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; December 6, 2012.

This announcement describes a labeling change designed to prevent calculation errors associated with heparin, a high-alert medication.

Free full text

Related Resources

Examples of Medical Device Misconnections.

March 8, 2023

ISMP survey on tall man (mixed case) lettering to reduce drug name confusion.

November 16, 2022

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up.

October 19, 2022

Advancing Anticoagulation Stewardship: A Playbook.

September 7, 2022

Adverse Health Events in Minnesota: Annual Reports.

August 9, 2022

National Prescription Drug Take Back Day.

July 16, 2022

Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry.

May 25, 2022

Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication.

October 20, 2021

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

Use purple bracelets or wristbands only for do not resuscitate status - letter to industry.

August 25, 2021

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

Accidental exposures to fentanyl patches continue to be deadly to children.

July 21, 2021

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings.

February 17, 2021

Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling.

February 10, 2021

FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.

February 3, 2021

Wear face masks with no metal during MRI exams.

December 16, 2020

Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers.

November 11, 2020

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Managing the risks of direct oral anticoagulants.

August 7, 2019

Medication Safety in Key Action Areas.

July 10, 2019

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

Defining minimum necessary anticoagulation-related communication at discharge: Consensus of the Care Transitions Task Force of the New York State Anticoagulation Coalition.

November 7, 2018

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.

February 7, 2018

RxAwareness.

October 25, 2017

Severe hyperglycemia in patients incorrectly using insulin pens at home.

October 25, 2017

See More About

Hospitals

Ambulatory Care

Health Care Providers

Patients

Medicine

To sign up for updates or to access your subscriber preferences, please enter your email address below.

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

Important change to heparin container labels to clearly state the total drug strength.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Important change to heparin container labels to clearly state the total drug strength.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

PSNet Log in

Submit Your Case

Continue as a Guest

Continue Logged In

Submit Your Case

Continue as a Guest

Already have a PSNet

Account?

New Users